2017
Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies
KRALICKOVA, P.; J. KUHNOVA; O. SOUCEK; P. VODAREK; P. ZAK et. al.Základní údaje
Originální název
Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies
Autoři
KRALICKOVA, P.; J. KUHNOVA; O. SOUCEK; P. VODAREK; P. ZAK; M. SIMKOVIC; M. MOTYCKOVA; L. SMOLEJ; E. MALA; C. ANDRYS; J. KREJSEK a Vojtěch THON
Vydání
Journal of Immunology Research, London, Hindawi, 2017, 2314-8861
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30102 Immunology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.298
Kód RIV
RIV/00216224:14110/17:00099077
Organizační jednotka
Lékařská fakulta
UT WoS
000419035800001
EID Scopus
2-s2.0-85042681248
Klíčová slova anglicky
Pneumococcal Capsular Polysaccharides; Natural Anti-Galactosyl; Humoral Immunodeficiencies
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 21. 3. 2018 16:27, Soňa Böhmová
Anotace
V originále
Humoral deficiencies represent a broad group of disorders. The aim of the study was to compare the levels of antibodies against pneumococcal capsular polysaccharides (anti-PCP) and natural anti-galactosyl (anti-Gal) antibodies in (1) patients with chronic lymphocytic leukaemia (CLL), (2) patients with common variable immunodeficiency (CVID), and (3) a healthy population and to explore their diagnostic and prognostic potential. Serum immunoglobulin levels and levels of anti-Gal IgG, IgA, and IgM and anti-PCP IgG and IgG2 were determined in 59 CLL patients, 30 CVID patients, and 67 healthy controls. Levels of IgG, IgA, IgM, anti-Gal IgA, anti-Gal IgM, and anti-PCP IgA were lower in CLL and CVID patients than in healthy controls. Decrease in the levels of IgA, IgM, anti-Gal IgA, and anti-PCP IgA was less pronounced in the CLL group than in the CVID group. IgA decline, anti-Gal IgA, anti-PCP IgA, and anti-PCP IgG2 were negatively correlated with CLL stage. We devise the evaluation of anti-Gal antibodies to be a routine test in humoral immunodeficiency diagnostics, even in cases of immunoglobulin substitution therapy. Significant reductions, mainly in anti-Gal IgA, IgM, and anti-PCP IgA levels, may have prognostic importance in CLL patients.